Reports and documents
Reports and documents
2022 Annual Financial Report – April 27, 2023
Half-year financial report 2022 – October 25, 2022
Investor presentation – BioMed Event – March 8, 2022
Half-year financial report 2021 – October 7, 2021
2020 Annual Financial Report – April 28, 2021
Information document – IPO on Euronext Paris – January 26, 2021
Investor presentation – IPO on Euronext Paris – January 26, 2021
Financial analyses
Invest Securities – Revolutionizing Drug Delivery (Purchase – Target € 12.2) – May 7, 2021